Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.7M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Actuate Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +9 vs. Q3 2024
- Shares held
- 10.1M
- +9.73M (+2,547.0%) vs. Q3 2024
- Total value
- $80.5M
- +$77.7M (+2,728.2%) vs. Q3 2024
- New holders
- 13
- 1 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $20.7M |
| Q1 2026 | 61 | $38.0M |
| Q4 2025 | 45 | $80.2M |
| Q3 2025 | 43 | $80.5M |
| Q2 2025 | 38 | $68.6M |
| Q1 2025 | 25 | $70.4M |
| Q4 2024 | 19 | $80.5M |
| Q3 2024 | 10 | $2.85M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Actuate Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 9,893,651 | $78.8M | 83.69% | +9,893,651 | New |
| Voss Capital, LLC | 55,246 | $439.8K | 0.03% | +55,246 | New |
| Geode Capital Management, LLC | 27,893 | $222.0K | 0.00% | 00.0% | Unchanged |
| Northwestern University | 27,778 | $221.1K | 0.35% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 16,344 | $130.1K | 0.00% | +16,344 | New |
| Sigma Planning Corp | 16,075 | $128.0K | 0.00% | +16,075 | New |
| Vanguard Group Inc | 14,296 | $113.8K | 0.00% | +14,296 | New |
| KG&L Capital Management,LLC | 12,000 | $95.5K | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 11,253 | $89.6K | 0.00% | +11,253 | New |
| Omers Administration Corp | 10,583 | $84.2K | 0.00% | +10,583 | New |
| Envestnet Asset Management Inc | 10,465 | $83.3K | 0.00% | +10,465 | New |
| Freestone Capital Holdings, LLC | 10,000 | $79.6K | 0.00% | +10,000 | New |
| BlackRock, Inc. | 7,745 | $61.7K | 0.00% | +7,745 | New |
| UBS Group AG | 1,934 | $15.4K | 0.00% | +1,934 | New |
| Morgan Stanley | 542 | $4.31K | 0.00% | +542 | New |
| Royal Bank of Canada | 302 | $2.00K | 0.00% | −34,998−99.1% | Reduced |
| Bank of America Corp | 24 | $191 | 0.00% | +1+4.3% | Added |
| JPMorgan Chase & Co | 3 | $24 | 0.00% | +3 | New |
| Citigroup Inc | 2 | $16 | 0.00% | −10,971−100.0% | Reduced |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −139,511−100.0% | Sold out |
| Long Corridor Asset Management Ltd | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,392−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −297−100.0% | Sold out |